Zhi Tong Cai Jing·2026-01-14 07:41Core Viewpoint - The domestic medical device market is transitioning to stable growth amid increasing pressure on medical insurance funds and comprehensive reforms in medical insurance payments, with "going global" becoming a strategic necessity for advanced domestic manufacturers [1] Group 1: Medical Equipment - High-end medical equipment has successfully moved beyond the stereotype of low-end replacements, with companies like United Imaging, Mindray, and MicroPort leading the charge into top-tier global medical systems with innovative products [2] - Establishing a global marketing network and supply chain is essential for the international business growth of medical devices, with companies like Yuyue Medical setting templates for localized operations through overseas subsidiaries [2] Group 2: High-Value Consumables - More domestic high-value consumables are obtaining FDA and EU certifications after initial experiences in Southeast Asia and South America, indicating growing international recognition of Chinese manufacturing [3] - Leading high-value consumables manufacturers are rapidly advancing their global strategies, with companies like Nanwei Medical acquiring major distributors and establishing factories in Thailand to mitigate policy risks [3] - Innovation is becoming a core competitive advantage for high-value consumables, with some products receiving breakthrough device designations from the FDA, showcasing significant clinical advancements [3] Group 3: Low-Value Consumables and IVD - The low-value consumables sector is undergoing a cleansing process, while the IVD sector is seeing steady growth in installed capacity, with expectations for increased reagent exports [4] - Companies like Mindray are exemplifying the IVD sector's international expansion through global marketing and supply chain integration, leading to sustained overseas performance [4]